Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Jacob

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Atherosclerosis|September 28, 2024
Corrigendum to "Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis" [Atherosclerosis, Vol 396, (September 2024), 118528], Andrew Krentz, Stephan Jacob, et al.
Magnetic Resonance in Medicine|April 12, 2002
MRI of muscular fatFritz Schick, Jürgen Machann, Klaus Brechtel, et al.
Atherosclerosis|August 18, 2024
Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis, Andrew Krentz, Stephan Jacob, et al.
Diabetes Technology & Therapeutics|July 10, 2010
Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim studyAndreas Pfützner, Michael Derwahl, Stephan Jacob, et al.
Diabetes, Obesity & Metabolism|May 13, 2022
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trialMonika Kellerer, Margit Staum Kaltoft, Jack Lawson, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 6, 2003
Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker ratErik J Henriksen, Mary K Teachey, Zachary C Taylor, et al.
The New England Journal of Medicine|September 11, 2025
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or ObesitySean Wharton, Ildiko Lingvay, Pawel Bogdanski, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Metabolic characterization of a woman homozygous for the Ser113Leu missense mutation in carnitine palmitoyl transferase IIMichael Haap, Claus Thamer, Jürgen Machann, et al.
Diabetes, Obesity & Metabolism|July 3, 2019
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized studyRichard E Pratley, Jahoon Kang, Michael E Trautmann, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 21, 2003
Lipid content in the musculature of the lower leg assessed by fat selective MRI: intra- and interindividual differences and correlation with anthropometric and metabolic dataJürgen Machann, Oliver P Bachmann, Klaus Brechtel, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Atherosclerosis|September 28, 2024
Corrigendum to "Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis" [Atherosclerosis, Vol 396, (September 2024), 118528], Andrew Krentz, Stephan Jacob, et al.
Magnetic Resonance in Medicine|April 12, 2002
MRI of muscular fatFritz Schick, Jürgen Machann, Klaus Brechtel, et al.
Atherosclerosis|August 18, 2024
Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis, Andrew Krentz, Stephan Jacob, et al.
Diabetes Technology & Therapeutics|July 10, 2010
Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim studyAndreas Pfützner, Michael Derwahl, Stephan Jacob, et al.
Diabetes, Obesity & Metabolism|May 13, 2022
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trialMonika Kellerer, Margit Staum Kaltoft, Jack Lawson, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 6, 2003
Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker ratErik J Henriksen, Mary K Teachey, Zachary C Taylor, et al.
The New England Journal of Medicine|September 11, 2025
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or ObesitySean Wharton, Ildiko Lingvay, Pawel Bogdanski, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Metabolic characterization of a woman homozygous for the Ser113Leu missense mutation in carnitine palmitoyl transferase IIMichael Haap, Claus Thamer, Jürgen Machann, et al.
Diabetes, Obesity & Metabolism|July 3, 2019
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized studyRichard E Pratley, Jahoon Kang, Michael E Trautmann, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 21, 2003
Lipid content in the musculature of the lower leg assessed by fat selective MRI: intra- and interindividual differences and correlation with anthropometric and metabolic dataJürgen Machann, Oliver P Bachmann, Klaus Brechtel, et al.
Pageof 5